The EU Commission will receive 30 million doses of the vaccine developed by Valneva against the new type of coronavirus, and will have the opportunity to receive 30 million doses.
It is stated that Valneva’s vaccine will contain an inactive virus, and Phase 3 studies of the vaccine have not started yet.
RELATED NEWS
Details of vaccine distribution process clarified
The EU Commission is holding vaccine purchasing negotiations and agreements on behalf of member countries. Until today, contracts have been signed with 6 companies for approximately 2.3 billion doses of vaccine.
restbet giriş yapmak için platformun yenilenen adresini kullanmanız gerekiyor.restbet501 yeni giriş adresi oldu ve artık bu adresi kullanmanız gerekiyor.
The Union, previously including options, to receive 600 million doses of vaccine with BioNTech-Pfizer, 400 million with AstraZeneca, 300 million with Sanofi-GSK, 400 million with Johnson and Johnson company, 405 million with CureVac, 160 million with Moderna. had made a contract.
AB’s preliminary negotiations with Novavax company other than Valneva on vaccination purchase were completed.
Source: AA
BENZER YAZILAR:
RESTBET POKER VAKA GÖRÜLMEDİĞİNİ İDDİA EDEN KUZEY KORE AŞI TALEP ETTİ
LIT RESTANT 500 TL BONUS AŞI YAPTIRAN HEMŞİRE ÖLDÜ: “HİÇBİR SAĞLIK SORUNU YOKTU”
RESTBET ONLİNE BAHİS AŞI OLDUKTAN 1 HAFTA SONRA KORONAVİRÜSE YAKALANDI
RESTBET BAHİS OYNA GETİR, İNGİLTERE’DE YATIRIM İÇİN 100 MİLYON DOLAR ARIYOR!
RESTBET501.COM TEK MAÇA OYNA
Laisser un commentaire